SP-3164, a Novel Cereblon-Binding Protein Degrader, Shows Activity in Preclinical Lymphoma ModelsDaniela Y. Santiesteban, Swaminathan P. Iyer, Sheila H. DeWitt et al.|Blood|2022Cited by 2
Abstract P087: Targeting LSD1 protein scaffolding function in FET-rearranged sarcomas with SP-2577Galen Rask, Daniela Y. Santiesteban, Emily R. Theisen et al.|Molecular Cancer Therapeutics|2021Cited by 1
Abstract 524: SP-3164, a novel ikaros and aiolos molecular glue degrader with preclinical activity in non-Hodgkin lymphomasDaniela Y. Santiesteban, Swaminathan P. Iyer, V. Jacques et al.|Cancer Research|2023Cited by 1
Abstract 6253: SP-3164, a novel molecular glue degrader with activity in preclinical models of multiple myelomaAundrietta D. Duncan, P. Leif Bergsagel, Daniela Y. Santiesteban et al.|Cancer Research|2023Cited by 1
P1241: A NOVEL CEREBLON-BINDING MOLECULAR GLUE, SP-3164, SHOWS PRECLINICAL ACTIVITY IN NON-HODGKIN LYMPHOMASDaniela Y. Santiesteban, Swaminathan P. Iyer, Sheila H. DeWitt et al.|HemaSphere|2023Cited by 0